We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$50.8B
AUM Growth
-$294M
(-0.58%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$255M |
| 2 |
Textron
TXT
|
+$206M |
| 3 |
AstraZeneca
AZN
|
+$164M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Moderna
MRNA
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$962M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$204M |
| 3 |
Devon Energy
DVN
|
+$201M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$170M |
| 5 |
Carrier Global
CARR
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 14.49% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Public Service Enterprise Group
PEG
$38.2B
| $73M | 0.14% |
1,198,884
+282,200
| +31% | +$17.6M |
|
152
Cigna
CI
$74.5B
| $73M | 0.14% |
364,598
-8,700
| -2% | -$1.89M |
|
153
S&P Global
SPGI
$123B
| $72.7M | 0.14% |
+171,005
| New | +$74.1M |
|
154
Advance Auto Parts
AAP
$3.36B
| $71M | 0.14% |
339,965
+169,065
| +99% | +$35.2M |
|
155
Ralph Lauren
RL
$22.6B
| $70.8M | 0.14% |
637,571
-311,700
| -33% | -$36M |
|
156
Ecolab
ECL
$78.6B
| $70.2M | 0.14% |
336,625
+106,200
| +46% | +$23.3M |
|
157
Jabil
JBL
$33.4B
| $69.8M | 0.14% |
1,196,445
+173,000
| +17% | +$10.3M |
|
158
Intercontinental Exchange
ICE
$85.2B
| $68.8M | 0.14% |
599,290
-8,700
| -1% | -$1.03M |
|
159
Assurant
AIZ
$14B
| $68.6M | 0.14% |
435,040
-50,900
| -10% | -$8.22M |
|
160
Otis Worldwide
OTIS
$27.5B
| $68.3M | 0.13% |
829,904
+230,999
| +39% | +$20.3M |
|
161
Dominion Energy
D
$60.5B
| $68M | 0.13% |
930,911
-95,645
| -9% | -$7.29M |
|
|
SIVB
162
DELISTED
SVB Financial Group
SIVB
| $67.5M | 0.13% |
104,338
+46,100
| +79% | +$26.7M |
|
163
Teledyne Technologies
TDY
$31.1B
| $67M | 0.13% |
155,913
+45,728
| +42% | +$20.2M |
|
164
Jazz Pharmaceuticals
JAZZ
$15.8B
| $66.1M | 0.13% |
507,394
+200,000
| +65% | +$30.2M |
|
165
Boston Scientific
BSX
$70.2B
| $65.9M | 0.13% |
1,519,016
-221,900
| -13% | -$9.82M |
|
166
Motorola Solutions
MSI
$72.6B
| $64.6M | 0.13% |
278,248
-7,600
| -3% | -$1.76M |
|
167
Colgate-Palmolive
CL
$71.6B
| $64.5M | 0.13% |
853,372
+188,952
| +28% | +$15M |
|
|
ERF
168
DELISTED
Enerplus Corporation
ERF
| $64.3M | 0.13% |
8,035,442
+2,718,766
| +51% | +$16.9M |
|
169
HCA Healthcare
HCA
$88B
| $64.2M | 0.13% |
264,400
-21,600
| -8% | -$5.28M |
|
170
Southern Company
SO
$107B
| $63.5M | 0.13% |
1,024,600
+613,700
| +149% | +$39.5M |
|
171
NXP Semiconductors
NXPI
$56.5B
| $62.9M | 0.12% |
321,208
-71,000
| -18% | -$14.7M |
|
172
Advanced Micro Devices
AMD
$790B
| $62.9M | 0.12% |
610,854
-5,280
| -0.9% | -$540K |
|
173
Estee Lauder
EL
$30.6B
| $62.7M | 0.12% |
208,984
+81,200
| +64% | +$26.5M |
|
174
Roper Technologies
ROP
$38.8B
| $62M | 0.12% |
138,921
+75,709
| +120% | +$36.3M |
|
175
Duke Energy
DUK
$96.9B
| $60.1M | 0.12% |
616,113
+154,053
| +33% | +$15.9M |
|
Similar funds
Adage Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
- Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
- Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
- Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
- Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
- Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
- Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.
Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.